InvestorsHub Logo
Followers 22
Posts 587
Boards Moderated 0
Alias Born 08/19/2020

Re: JJPow post# 16213

Friday, 08/28/2020 10:57:52 AM

Friday, August 28, 2020 10:57:52 AM

Post# of 44695
Yes. And this is impressive:

"All patients had known chronic diseases. The most common comorbidities prior to admission were hypertension (4/6) and chronic kidney disease (4/6). Two patients have known diabetes mellitus, with Patient 6 being insulin-dependent. Three of the patients had undergone solid organ transplants and were treated with immunosuppressive agents. Patient 2 received a double lung transplant and was treated for antibody-mediated rejection (AMR) one month before presentation. Patient 1 was also diagnosed with a non-ST-elevation myocardial infarction (NSTEMI) during her admission (Table 1). All patients had lab values suggestive of diffuse inflammatory processes including elevated ferritin (5/6), IL-6 (4/6), lactate dehydrogenase (3/6), and C-reactive protein (3/6)."

I think they are getting their ducks in a row to prepare for all the inevitable scrutiny. The cases and overall results are not new, but these details are new... and very impressive.

Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.